Merit Medical Systems | MMSI - Bruttoergebnis Vom Umsatz

Aktienkurs
71.43
Täglich Wechseln
0.86 1.22%
Monatlich
3.27%
Jährlich
-22.32%
Q2 Prognose
66.40




Bruttoergebnis Vom Umsatz Veränderung Datum
3M USD 2.06B 667M 2025-12
Abbott USD 6.54B 625M 2025-12
AngioDynamics USD 44.78M 2.93M 2025-09
Anika Therapeutics USD 19.18M 3.6M 2025-12
AtriCure USD 105.34M 4M 2025-12
Baxter International USD 577M 373M 2025-12
Becton, Dickinson and Co. USD 2.41B 1.72B 2025-12
Boston Scientific USD 3.68B 136M 2025-12
Cooper Companies USD 695.2M 44.4M 2025-12
Dexcom USD 792.7M 61.3M 2025-12
Edwards Lifesciences USD 1.23B 18.7M 2025-12
Globus Medical USD 535.95M 49.28M 2025-12
Haemonetics USD 202.39M 7.64M 2025-12
Hologic USD 586.4M 2.9M 2025-12
ICU Medical USD 202.98M 2.1M 2025-12
Insulet USD 568.6M 58.5M 2025-12
Integra LifeSciences USD 217.1M 10.11M 2025-12
J&J USD 16.6B 118M 2025-12
Medtronic USD 5.41B 27M 2025-12
Merit Medical Systems USD 195.35M 8.94M 2025-12
Olympus JPY 164.9B 3.6B 2025-12
Pfizer USD 3.54B 7.61B 2025-09
STAAR Surgical USD 43.74M 34.13M 2025-12
Stryker USD 4.49B 633M 2025-12
Surmodics USD 20.08M 31.62M 2025-06
Tandem Diabetes Care USD 167.46M 33.17M 2025-12
Teleflex USD 307.45M 144.2M 2025-12
Terumo JPY 153.19B 6.2B 2025-12
Zimmer Biomet Holdings USD 1.27B 8.1M 2025-12